Cargando…
Sex differences in ADR reports for drugs used to treat COVID-19
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530853/ http://dx.doi.org/10.1007/s40278-020-83979-0 |
Ejemplares similares
-
Quality of ADR reporting evaluated for remdesivir trials of COVID-19
Publicado: (2020) -
Reported ADRs with chloroquine or hydroxychloroquine
Publicado: (2021) -
High incidence of ADRs in COVID-19 patients in China
Publicado: (2020) -
Reported rates of CVST due to COVID-19 vaccination rose after publicising these ADRs
Publicado: (2022) -
Increase in thromboembolic ADRs from oral contraceptives during COVID-19 pandemic in Spain
Publicado: (2022)